Clinical Trial Update: Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the safety and immunogenicity of the GSK Meningococcal Group B Vaccine when administered concurrently with the GSK Meningococca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• GSK Meningococcal Group B Vaccine
• GSK Meningococcal MenACWY Conjugate Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2025-03-04